Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


15.04.2019

1 Anticancer Res
1 BMC Cancer
1 Clin Nucl Med
2 J Clin Endocrinol Metab
2 J Endocrinol Invest
1 PLoS One
5 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. OKI T, Sugimoto T, Ogawa M, Dabanaka K, et al
    Evaluation of Follow-up Examinations Using Ultrasonography for Patients With Thyroid Nodules Initially Diagnosed as Benign.
    Anticancer Res. 2019;39:2061-2067.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. BEUKHOF CM, Brabander T, van Nederveen FH, van Velthuysen MF, et al
    Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls.
    BMC Cancer. 2019;19:325.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  3. KIM IH, Yoon JK, Lee SJ, Jeong E, et al
    A Case of Radioactive Iodine Uptake Found in Artificial Eye.
    Clin Nucl Med. 2019;44:317-318.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  4. GARRAHY A, Murphy NP, Byrne MM
    Letter to the Editor: "Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features".
    J Clin Endocrinol Metab. 2019 Apr 12. pii: 5445414. doi: 10.1210/jc.2018-02435.
    PubMed     Text format    

  5. THAKAR R, Gajewska-Knapik K, Ogilvy-Stuart AL, Chatterjee K, et al
    Response to Letter to the Editor: "Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features".
    J Clin Endocrinol Metab. 2019 Apr 12. pii: 5445418. doi: 10.1210/jc.2018-02593.
    PubMed     Text format    


    J Endocrinol Invest

  6. COZZAGLIO L, Zuccarelli A, Quagliuolo V
    Financial benefit in outpatient thyroid surgery.
    J Endocrinol Invest. 2019 Apr 5. pii: 10.1007/s40618-019-01043.
    PubMed     Text format    

  7. MALANDRINO P, Tumino D, Russo M, Marescalco S, et al
    Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend.
    J Endocrinol Invest. 2019 Apr 8. pii: 10.1007/s40618-019-01044.
    PubMed     Text format     Abstract available


    PLoS One

  8. NAM JY, Choi Y, Jung MK, Shin J, et al
    The effect of neonatal hypothyroidism and low family income on intellectual disability: A population-based cohort study.
    PLoS One. 2018;13:e0205955.
    PubMed     Text format     Abstract available


    Thyroid

  9. GRULET H, Barraud S, Chikh K, Souchon PF, et al
    Three consecutive pregnancies in a patient with chronic autoimmune thyroid disease associated with hypothyroidism and extremely high levels of anti-TSH receptor antibodies.
    Thyroid. 2019 Apr 11. doi: 10.1089/thy.2018.0098.
    PubMed     Text format     Abstract available

  10. BELLASTELLA G, Caputo M, Maiorino MI, Longo M, et al
    EMPATHY: A new tool for identifying the most suitable thyroxine formulation in hypothyroid patients.
    Thyroid. 2019 Apr 9. doi: 10.1089/thy.2018.0493.
    PubMed     Text format     Abstract available

  11. HAN C, He X, Xia X, Guo J, et al
    Sphk1/S1P/S1PR1 signaling is involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2h4 Mice.
    Thyroid. 2019 Apr 9. doi: 10.1089/thy.2018.0065.
    PubMed     Text format     Abstract available

  12. WANG Y, Liyanarachchi S, Miller KE, Nieminen TT, et al
    Identification of rare variants predisposing to thyroid cancer.
    Thyroid. 2019 Apr 8. doi: 10.1089/thy.2018.0736.
    PubMed     Text format     Abstract available

  13. CHO GJ, Kim SY, Lee HC, Lee KM, et al
    The risk of adverse obstetric outcomes and the abnormal growth of offspring in women with a history of thyroid cancer.
    Thyroid. 2019 Apr 8. doi: 10.1089/thy.2018.0283.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: